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Summary 
Tyrosine aminotransferase (TAT) gene expression is 
liver specific and inducible by glucocorticoids and via 
the cAMP signaling pathway. In fibroblasts and other 
nonliver cells the gene is subject to negative control 
by the trans-dominant tissue-specific extinguisher lo- 
cus Be-l. We identified a hepatocyte-specific enhancer 
that is repressed by Tse-7. Two distinct sequence mo- 
tifs are absolutely essential for function of this en- 
hancer: a CAMP response element (CRE), which is the 
target for repression by Tse-7, and a hepatocyte-specific 
element. The specificity of the enhancer is generated 
by the combination of these two essential elements, 
which are fully interdependent. In vivo footprinting in- 
dicates that Be-1 acts by affecting protein binding at 
the CRE. A direct antagonism between Be-1 and the 
CAMP signaling pathway suggests that Tse-l plays a 
role in control of developmental activation of the TAT 
gene. 
Introduction 
Somatic cell fusion experiments provided the first evi- 
dence that diffusible factors acting in trans are involved in 
control of cell type-specific gene expression (for reviews 
see Davis and Adelberg, 1973; Davidson, 1974). Hybrid 
cells generated by fusing distinctly differentiated cells ei- 
ther fail to express tissue-specific gene products of either 
parent, a phenomenon termed extinction (Davidson et al., 
1966; Schneider and Weiss, 1971; Sparkes and Weiss, 
1973), or activate silent genes of one fusion partner (Peter- 
son and Weiss, 1972; Brown and Weiss, 1975). This has 
been observed in both heterokaryons and proliferating hy- 
brid cells (MeveCNinio and Weiss, 1981; Blau et al., 1985). 
Killary and Fournier (1984) have shown that extinction in 
hepatoma x fibroblast hybrids has a specific genetic ba- 
sis. They have defined a locus on mouse fibroblast chro- 
mosome 11 and its human homolog 17, the tissue-specific 
extinguisher 1 (Be-l), which represses hepatoma-specific 
expression of tyrosine aminotransferase (TAT). Tse-7 is not 
syntenic with the structural gene encoding mouse TAT 
that has been mapped to chromosome 8 (Miiller et al., 
1985). In monochromosomal hybrids expression of the 
TAT structural genes of both parental cell types is deter- 
mined by the presence or absence of fibroblast Tse-7 
(Peterson et al., 1985). TAT expression is equally extin- 
guished in hepatoma microcell hybrids containing chro- 
mosome 11 from several other mouse donor cell lines de- 
rived from any of the three primary germ layers (Gourdeau 
et al., 1989). Together, this suggests a role for Tse-7 in con- 
trol of liver-specific expression of TAT. 
Regulation by Tse-7 is highly target gene specific. Only 
a subset of liver-specific genes, including TAT, is coor- 
dinately repressed by Tse-7 (Lem et al., 1988; Thayer and 
Fournier, 1989; Ruppert et al., 1990). These target genes 
share additional characteristics of regulation. They are all 
inducible via the CAMP pathway and by glucocorticoids, 
and their expression is dependent on the presence of a 
second regulatory locus residing on mouse chromosome 
7 (see Ruppert et al., 1990). In karyotypically complete 
hepatoma x fibroblast hybrids virtually all liver-specific 
traits are extinguished (Chin and Fournier, 1987). This 
suggests the existence of additional extinguisher loci 
regulating distinct sets of liver-specific genes. A locus 
residing on mouse chromosome 1, termed Tse-2, repres- 
ses expression of serum albumin and alcohol dehydrog- 
enase (Petit et al., 1986; Chin and Fournier, 1989). 
Nothing is known to date about the products of extin- 
guisher loci. As these trans-dominant factors are defined 
by genetic experiments, which allow identification of regu- 
latory factors not necessarily binding to DNA, it is particu- 
larly attractive to investigate their mechanism of action. 
Since Tse-7 exerts its effect largely through transcriptional 
control (A. F. Stewart and E. Schmid, unpublished data), 
we have decided to approach the underlying mechanisms 
by determining the c&-acting sequences mediating re- 
pression of rat TAT gene transcription by Tse-7. 
The TAT gene also provides an excellent model to study 
how cell type-specific factors and hormonal signal trans- 
duction pathways interact and control the correctly timed 
establishment of liver-specific gene expression. TAT ex- 
pression is restricted to parenchymal cells of the liver 
(Hargrove and Granner, 1985). Transcription of the gene 
can be induced by glucocorticoids and by glucagon act- 
ing via the CAMP pathway (Granner and Beale, 1985; 
Hashimoto et al., 1984; Schmid et al., 1987). TAT expres- 
sion is undetectable before birth but increases rapidly 
within the first hours after birth (Greengard, 1970). Levels 
of glucocorticoids and hormones acting via the CAMP 
pathway also increase in the newborn, owing to postnatal 
hypoglycemia. These hormones seem to play a role in 
triggering the developmentally programmed onset of ex- 
pression, as premature activation of the TAT gene can be 
elicited by administration of glucagon (acting via CAMP) 
in utero and this effect is enhanced by glucocorticoids 
(Greengard, 1970; Ghisalberti et al., 1980; Ruiz-Bravo and 
Ernest, 1982). 
A link between control of cell type-specific transcription 
and hormonal signal transduction was suggested tjy the 
observation that induction via the CAMP pathway could re- 
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verse repression by Tse-7 in monochromosomal hepa- 
toma hybrids (Thayer and Fournier, 1989; Ruppert et al., 
1990). Here we show that Tse-7 represses the activity of 
a hepatocyte-specific enhancer that we identified 3.6 kb 
upstream of the start site of TAT transcription. A CAMP re- 
sponse element (CRE), which is an essential component 
of this enhancer, mediates repression by Tse-7. 
Results 
A Hepatocyte-Specific Element Is Located 
Far Upstream of the TAT Promoter 
To identify &-acting sequences important for restriction 
of TAT gene transcription to hepatocytes, we performed 
gene transfer into several cell lines of either hepatic, epi- 
thelial, or mesenchymal origin. The TAT gene is expressed 
in the well-differentiated rat hepatoma cell line FTO-26 
(Killary et al., 1984; Killary and Fournier, 1984) at a rate 
similar to that in liver. The rat hepatoma line HTC (Thomp- 
son et al., 1966) shows approximately lo-fold lower levels 
of TAT mRNA than FTO-26. In both cell lines TAT tran- 
scription can be induced by glucocorticoids, but only in 
FTC&26 does it respond to induction via the CAMP pathway. 
Neither the human hepatoma line HepG2 (Knowles et al., 
1980) the human cervical adenocarcinoma line HeLa, nor 
the rat fibrosarcoma cell line XC (Svoboda, 1960) expres- 
ses detectable amounts of TAT (data not shown). Thus, 
high level expression of the TAT gene is restricted to 
differentiated hepatoma cell lines, which reflects hepato- 
cyte-specific expression observed in vivo. 
DNAase I hypersensitive site mapping had indicated 
the presence of a hypersensitive site 3.6 kb upstream of 
the start site of transcription of the TAT gene in chromatin 
from liver and differentiated hepatoma cells, but not from 
nonexpressing kidney cells or fibroblasts (D. Nitsch, A. F. 
Stewart, M. B., R. Mestril, F. W., and G. S., submitted). 
Expression of a TATCAT (CAT = chloramphenicol acetyl- 
transferase) fusion construct encompassing 3341 bp of 
TAT upstream sequences (TATCAT -3341/+62) was low in 
all five cell lines as compared with CAT expression driven 
by the herpes simplex virus thymidine kinase (HSV TK) 
promoter. With construct TATCAT -3922/+62 we noted a 
more than 50-fold increase in CAT expression in the well- 
differentiated rat hepatoma line FTO-26, but no change in 
any of the other cell lines (Table 1). This suggests an im- 
portant role of the region between -3922 and -3341 in 
control of liver-specific expression of the TAT gene. 
TAT Regulatory Sequences Are Responsive 
to the Product of the Tissue-Specific 
Extinguisher Locus ke-7 
As the tissue-specific extinguisher locus Tse-7 is thought 
to play an important role in restricting TAT expression to 
cells of hepatic origin, we asked whether a TATCAT fusion 
construct including the hepatocyte-specific element would 
respond to the presence of Tse-7. To this end, we made 
use of cell lines constructed by microcell fusion of human 
chromosome 17 derived from fibroblasts with a subclone 
of the rat hepatoma line FTO-2B (Lem et al., 1988; Leach 
et al., 1989). The resulting cell line 7AE27 retains several 
Table 1. Liver Cell-Specific Expression of a TATCAT 
Fusion Construct 
Relative CAT Activity m Extracts from 
Transfected Cell Lines? 
Construct FTO-26 HTC XC HepG2 HeLa 
PBLCAT~~ 100 100 100 100 100 
TATCAT - 3341 I + 62 35 13 4 19 25 
TATCAT - 3922/ + 62 1941 14 3 17 30 
a FTO-26 ceils were transfected by lipofection (see Experimental 
Procedures). All other cell lines were electroporated under identical 
conditions (see Experimental Procedures). A luciferase expression vec- 
tor (RSVIucNH) was included as internal reference. After 50 hr, ex- 
tracts were prepared and assayed for CAT and luciferase activity 
Relative CAT activity was calculated by correcting CAT expression for 
luciferase expression and setting the activity of pBLCAT2 arbitrarily 
to 100 for each cell line. Absolute values for pBLCAT2 are 0.6 pmollmin 
per mg in FTO-26, 19 pmollmin per mg in HTC, 395 pmol/min per mg 
in XC, 12 pmollmin per mg in HepGP, and 10 pmollmin per mg in HeLa 
cells. Data from representative transfection experiments are shown 
throughout this paper. Each construct has been tested in at least three 
independent experiments, using two different plasmid preparations in 
most cases. 
b HSV TK promoter fused to CAT (Luckow and Schutz, 1967). 
markers from the long arm of human chromosome 17 in- 
cluding the Tse-7 locus and expresses the human Tse-7 
product on a rat hepatoma background. As a control, we 
used 7AD7, which retains most of these markers on the 
same hepatoma background but lacks the Tse-7 locus. 
This cell line displays identical properties as the parental 
line FTO-28. A construct encompassing 4289 bp of TAT up- 
stream sequences (TATCAT -4289/+62) was transfected 
into these cell lines along with a number of control plas- 
mids that should not respond to Tse-7. The SV40 enhancer/ 
promoter, the Rous sarcoma virus long terminal repeat 
(RSV LTR), and the HSV TK promoter are known to be ac- 
tive in many cell types. Expression of a,-antitrypsin and 
albumin is liver specific, but these genes do not respond 
to Tse-7 (Killary and Fournier, 1984; R. E. K.. F., unpub- 
lished data). As expected, we found the levels of expres- 
sion of the various control constructs almost identical in 
the two cell lines 7AD7 (Tse-7-) and 7AE27 (Tse-7+) (Table 
2). Only expression of TATCAT -4289/+62 was about 60- 
fold reduced in 7AE27 (Tse-7+). This dramatic and gene- 
specific inhibition of CAT expression correlates with the 
presence of Tse-7 activity, suggesting that TAT upstream 
sequences include a Tse-7 response element. 
It had previously been noted that induction via the 
CAMP pathway could antagonize the Tse-7 effect on TAT 
gene expression in hepatoma microcell hybrids (Thayer 
and Fournier, 1989). Therefore, in the experiment pre- 
sented in Table 2 we included inductions with forskolin, a 
drug that activates adenylate cyclase and thereby raises 
intracellular CAMP levels (Seamon et al., 1981). We noted 
only a minor effect of forskolin treatment on expression of 
TATCAT -4289/+62 in the control cell line 7AD7 (Tse-7-), 
but an approximately 75fold induction of CAT expression 
from this construct in the presence of Tse-7 (in 7AE27). The 
induced level of expression in 7AE27 (Tse-7+) was close to 
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Table 2. Repression by Jse-7 Is Highly Target Specific 
Relative CAT Activity in Extracts from Transfected Cell Lines? 
7AD7 (Tse- 1 -) 7AE27 (Tse- I+) 
Construct Uninduced 10 nM Forskolin Fold Uninduced 10 uM Forskolin Fold 
pSV2catb 100 69 0.7 100 83 0.8 
pRSVCATC 1324 1416 1.1 857 1278 1.5 
pBLCAT2 38 34 0.9 49 86 1.8 
pTK14Cd 3860 3964 1 .o 3006 2705 0.9 
Human a,-antitrypsin 39 37 1 .o 44 38 0.9 
- 1200/ + 44e 
Rat albumin - 151/+4’ 20 33 1.6 15 47 3.0 
TATCAT - 4289/+ 62 355 540 1.5 6 466 75 
a Duplicate plates were transfected by lipofection (see Experimental Procedures). RSVIucAIH was included as internal reference. Twenty-two hours 
prior to harvest one plate was induced with 10 NM forskolin; the other was treated with 0.1% ethanol as solvent control. The total expression period 
was 65 hr. CAT activity was corrected for luciferase activity and for protein and is given as relative activity, arbitrarily setting the activity of pSV2cat 
to 100. Absolute values for uninduced pSV2cat are 1.2 pmollmin per mg in 7AD7 and 2.7 pmollmin per mg in 7AE27 cells. 
b SV40 enhancer/promoter fused to CAT (Gorman et al., 1982). 
c RSV LTR fused to CAT (Gorman et al., 1982). 
d Two copies of the SV40 enhancer in front of the TK promoter (R. Miksicek and G. S.. unpublished data). 
e Ciliberto et al., 1985. 
’ Heard et al., 1987. 
Tss-1 0 Tsa-1 
@ 
9 ?A07 7AE27 : :: 
;-r-----i; 0 
=c-+c-+ n. 
404- 
c 
c-IlltBD -!B? -US SOS- 
Figure 1. Start Site Mapping of TATCAT mRNA 
TATCAT -4289/+62 was introduced into 7AD7 (Tse-l-) and 7AE27 
@e-l+) cells by lipofection as described in Experimental Procedures. 
Cells were split onto duplicate plates 20 hr after transfection. Thirty 
hours after splitting, the cells were induced with 10 uM forskolin or 
treated with 0.1% ethanol as solvent control in serum-free medium. 
RNA was extracted 67 hr after addition of the DNA-lipid complex. One 
hundred micrograms of total RNA from untransfected, uninduced con- 
trol cells (c), and uninduced (-) and induced (+) transfected cultures 
was hybridized to 10 fmol (1.6 x 10s dpm) of a uniformly labeled, gel- 
purified antisense riboprobe overlapping the start site of transcription. 
The samples were digested with RNAase A and T, and loaded onto 
an 8% polyacrylamide-urea gel. The size of Hpall-cut pBR322 marker 
fragments is given in base pairs on the left. The expected fragments 
protected from RNAase digestion are shown in the diagram with their 
calculated sizes. The autoradiogram was exposed for 12 hr. Weak 
bands in the untransfected control lanes may result from incomplete 
digestion of the probe. 
the level measured in 7AD7 (Be-l-). Thus, raised intra- 
cellular levels of CAMP reverse the Tse-7 effect. In the hy- 
brid clone 7AE27, full reversion of Tse-l-mediated repres- 
sion of the endogenous TAT gene required combined 
induction via the CAMP pathway and by glucocorticoids 
(see Ruppert et al., 1990). This was not observed for the 
transfected constructs. 
To ascertain that the observed effects on CAT expres- 
sion were due to changes in abundance of CAT mRNA 
correctly initiated at the start site of TAT gene transcrip- 
tion, we performed a ribonuclease protection experiment 
with RNA of transfected 7AD7 (Tse-l-) and 7AE27 (Tse-7+) 
cells. The relative abundance of correctly initiated TATCAT 
transcripts was in good agreement with the values ob- 
tained from CAT enzymatic assays (Figure 1). 
A Hepatocyte-Specific Enhancer 3.6 kb Upstream 
of the TAT Promoter Is a Target for Tse-1 Action 
To determine the boundaries of the hepatocyte-specific 
element far upstream of the TAT promoter (see Table l), 
we constructed a series of 5’ and 3’ internal deletion mu- 
tants (TATCAT series, Figure 2A). With deletions from the 
5’ end, CAT activity in 7AD7 (Tse-7-) cells decreased in 
two steps, about 2-fold between -3816 and -3709 and 
about 50-fold between -3881 and -3628. No further de- 
crease was observed between -3628 and -351, indicat- 
ing that the residual activity of TATCAT -3628/+82 re- 
flected the basal activity of the TAT promoter (data not 
shown). Internal deletions from the 3’side of the relevant 
region (starting from -3341) led to a dramatic loss of activ- 
ity between -3581 and -3589. Thus, an essential region 
designated domain B in Figure 28 could be localized be- 
tween -3661 and -3581. Any further deletion into this 80 
bp fragment led to total loss of enhancer function, and 
CAT expression was reduced to the basal level of the TAT 
promoter. The region downstream of -3581, contributing 
a moderate effect, was designated domain C in Figure 28. 
Cell 
906 
3’ Intwnal dolotIon* 
Figure 2. Deletion Analysis of the Cell Type-Specific Enhancer 
(A) The Sand 3’ internal deletion constructs shown in the diagram were transfected mto 7AD7 (Jse-7.) cells by lipofection (see Expenmental Proce- 
dures). As internal reference, RSVlucAlH was included. Seventeen hours after addition of the DNA-lipid complex, medium was changed and incuba- 
tion continued in serum-free medium. Cellular extracts were prepared after 63 hr and assayed for CAT and luciferase activity. Luciferase-corrected 
CAT activity was calculated as relative activity by arbitrarily setting the value of the largest construct (TATCAT -4269/+62, 160 pmollmrn per mg) 
to 100. Numbers to the left of the diagram indicate the deletion endpoints in base pairs relative to the start site of transcription. 
(6) In the upper part of the diagram, domains A, B, and C of the enhancer are shown as deduced from the data presented in (A). For comparison, 
endpoints of the 5’and B’internal deletion constructs used in (A) are indicated as arrows pointing to the right (5’deletions) or to the left (Ydeletions). 
The relative CAT activities taken from (A) are indicated on top of the arrows. Subfragments from the enhancer region, which were placed in sense 
orientation in front of the TK promoter, are drawn as thin lines. Numbers to the left and right of these lines indicate the position of the first or last 
base pairs of TAT sequence relative to the start site of transcription. 
These constructs (TTC series) were transfected into 7AD7 (Jse-IT) and 7AE27 @e-l’) cells by lipofection. Twenty hours after addition of the 
DNA-lipid complex, cells were split onto duplicate plates, incubated for 5 hr in serum-containmg medium to allow attachment to the culture dash 
and then induced in serum-free medium with 10 uM forskolin (plus sign in the table) or 0.1% ethanol as solvent control (minus sign in the table). 
Cells were harvested after a total expression period of 63 hr. CAT activity was determined, corrected for protein, and is given in the table as fold 
stimulation of the uninduced TK promoter in pBLCAT2. arbitrarily set to 1. Absolute values for pBLCAT are 0.75 pmollmin per mg rn 7AD7 and 0.74 
pmollmin per mg in 7AE27. 
The weak effect contributed by sequences between -3661 
and -3816 defined domain A. Domains A and C were 
both dependent on an intact domain 6 and were not fur- 
ther investigated. 
A hepatocyte-specific positive element seemed to us a 
likely target of Tse-7 action. Therefore, we placed a 337 bp 
restriction fragment spanning domains A, B, and part of 
C in front of the heterologous HSV TK promoter and as- 
sayed this construct (TTC337) in the cell lines 7AD7 (Tse- 
7-) and 7AE27 @e-l+) with or without induction by for- 
skolin (Figure 28). The TAT sequences stimulated the TK 
promoter about 130-fold in 7AD7 (Tse-l-) but only weakly 
responded to forskolin. In the presence of lse-7 (in 7AE27 
cells) hardly any effect of these TAT sequences on the TK 
promoter was seen in uninduced cells, whereas forskolin 
induced expression approximately 80-fold. The element 
was equally active in both orientations in front of the TK 
promoter and was independent of distance in front of both 
the TAT and TK promoters (data not shown). Thus, Tse-7 
acts via a hepatocyte-specific enhancer. Smaller subfrag- 
ments from the enhancer region were then tested in front 
of the TK promoter (Figure 28). The results were in agree- 
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Frgure 3. Scan of Clustered Point Mutations through Domain B of the Enhancer 
(Top) The TAT upstream sequence from -3561 to -3660 is shown. The positions of 17 clustered point mutations and the respective mutant se- 
quences are indicated by brackets. Above the sequence, brackets mark the positions of synthetic oligonucleotides 81 and Bill. 
(Bottom) 7AD7 @e-l--) cells were transfected by lipofection (see Experimental Procedures) with the wild-type (wt) construct TATCAT -4289/+62 or 
the 17 mutants (Ml to M17). RSVlucAlH was included as internal reference. Cells were kept in serum-free medium throughout the expression period 
of 65 hr. CAT activity was corrected for luciferase activity and is given as relative actrvity, arbitrarily setting the wt construct to 100. The absolute 
value for the wt construct is 216 pmollmin per mg. 
ment with the deletion analysis of the enhancer in its natu- 
ral posiiion 3.6 kb upstream of the TAT promoter. Most im- 
portantly, all fragments retaining enhancer activity were 
repressed by Be-7 and were strongly inducible with for- 
skolin in the presence of Tse-1. We conclude that the se- 
quences essential for enhancer function, repression by 
Tse-7, and reversal of Tse-7 repression by CAMP all map 
to domain B. 
A CRE-Like Sequence and a Second Motif Are Both 
Essential for Enhancer Function 
To dissect the elements responsible for this complex regu- 
lation, we carried out a systematic scan with clustered 
point mutations through domain B of the TAT enhancer. 
Transversion mutations were generated in their natural po- 
sition 3.6 kb upstream of the TAT promoter and were tested 
in 7AD7 (Tse-l-) cells (Figure 3). We detected two distinct 
motifs that are absolutely essential for enhancer function. 
Three base changes in mutant M3 led to a 40-fold de- 
crease in activity. Mutation of a second motif defined by 
Ml2 and Ml3 also reduced enhancer function about 50- 
fold, which is equivalent to total deletion of the enhancer 
(see Figure 2A). Therefore, this cell type-specific en- 
hancer shows little redundancy of elements. Furthermore, 
the two essential regions are interdependent. The BI motif 
mutated in M3 resembles CREs of several genes (Comb 
et al., 1986; Montminyet al., 1986; Delegeane et al., 1987; 
Silver et al., 1987; Tsukada et al., 1987; Quinn et al., 1988; 
Fisch et al., 1989). In mutant M2 we changed the CRE-like 
motif to a perfect CRE consensus sequence (CTGACGT- 
CAG). The neutral phenotype of M2 is in agreement with 
the observation that the TAT motif is a functional CRE (see 
below and F W., A. F. Stewart, M. B., D. Nitsch, and G. S., 
submitted). We noted similarity of the Bill motif to the bind- 
ing sites for hepatoma-specific factors in the enhancer of 
the human hepatitis B virus (Shaul and Ben-Levy, 1987) 
and to sequences in the liver-specific core promoter re- 
gion of the human hepatitis B virus (Yee, 1989). 
We have tested the same set of mutants in the presence 
of Tse-7. None of our mutants affected negative regulation 
by Tse-7 (data not shown). This suggests that repression 
by Tse-7 is mediated by sequences identical to or overlap- 
ping with one or both of the motifs essential for basal en- 
hancer function. 
The Two Essential Motifs Cooperate and Together 
Are Sufficient to Confer the Regulatory 
Properties of the Enhancer 
To test the two essential motifs individually, we had to 
overcome their interdependence. Therefore, we cloned 
tandem dimers of the oligonucleotides shown in Figure 3, 
designated BI and 8111, in front of the HSV TK promoter. 
In addition, mutant versions of the BI dimer were made. 
These constructs were transfected into 7AD7 (Tse-l-) 
cells, and CAT activity was measured from uninduced or 
forskolin-induced cultures (Figure 4). The BI dimer, which 
includes the CRE-like motif, clearly behaves as a CRE, 
with about g-fold stimulation of the TK promoter upon 
forskolin treatment. The reverse orientation of the BI dimer 
conferred CAMP responsiveness to an equal extent, where- 
as constructs with a monomer of the BI oligonucleotide in 
either orientation were inactive (data not shown). The 
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Figure 4. Two Essential Regions of the En- 
hancer Cooperate and Are Sufficient for Regu- 
lated Function 
7AD7 (tie-l-) cells were transfected by lipofec- 
tion (see Experimental Procedures) with the 
constructs symbolized in the diagram. Nme- 
teen hours after addition of the DNA-lipid com- 
plex, cells were split onto duplicate plates, in- 
cubated for 3 hr in serum-containing medium 
to allow attachment to the culture dash, and 
then induced in serum-free medium with 10 PM 
forskolin or 0.1% ethanol as solvent control. 
Cells were harvested after a total expression 
period of 49 hr. CAT activity was determined, 
corrected for protein, and is given as fold stem- 
ulation of the uninduced TK promoter in pBL- 
CAT2. arbitrarily set to 1. The absolute value for 
uninduced pBLCAT2 is 0.63 pmollmin per mg. 
The sequences of oligonucleotides BI and 
Bill are given in Figure 3. El was synthesized with Xbal and Spel sticky ends (SIX additional nucleotides) and cloned in sense orientation into the 
Xbal site of pBLCAT2. Bill was synthesized with Bglll and BamHl sticky ends (three additional nucleotides) and cloned in sense orientation into 
the BamHl site of pBLCAT2. Mutant versions of the oligonucleotides include the cluster of point mutations given in the bracket (see Figure 3 for 
mutant sequence). Construct TTCBO includes sequences from -3582 to -3661 and represents the complete B domain. 
CRE-like sequence motif was required for inducibility by 
CAMP as three point mutations in this sequence abolished 
inducibility (BI(M3) dimer), whereas mutations in adjacent 
sequences (BI(M4/5) dimer) were neutral. Elsewhere, we 
have analyzed the mechanism of CAMP-mediated signal 
transduction to this CRE (F. W., A. F. Stewart, M. B., D. 
Nitsch, and G. S., submitted). Similarly, a dimer, but not 
a monomer, of the Bill oligonucleotide (see Figure 3) 
strongly activated the TK promoter, but was unaffected by 
forskolin treatment (Figure 4). These findings suggest a 
strong synergism between a CRE and a constitutive ele- 
ment, both being essential components of the enhancer. 
The TATCRE has a dual role: it mediates response to 
CAMP, and in cooperation with the Bill motif, it assures 
high basal activity of the enhancer. The enhancer activity 
is only weakly modulated by forskolin induction in 7AD7 
(tie-l-) cells. Maximal induction of the transcription rate 
of the endogenous TAT gene is, however, transient and 
declines after 60 min (F. W., A. F Stewart, M. B., D. Nitsch, 
and G. S., submitted). Therefore, in transient gene trans- 
fer experiments, inducibility of TATCAT constructs becomes 
apparent only when the basal enhancer activity is re- 
pressed by Tse-1. 
We have then directly tested synergism between BI and 
Bill by constructing a heterodimer of the two oligonucleo- 
tides. As controls and to rule out any effect of spacing or 
sequence environment, we also constructed mutant ver- 
sions of this heterodimer in which either of the two motifs 
was destroyed by the M3 or the Ml2 cluster of point muta- 
tions. As expected, no stimulation of the TK promoter was 
observed with the mutant versions. The intact BVBIII 
heterodimer increased expression about 18fold and re- 
sponded to forskolin. The somewhat lower level of activity 
of the BVBIII heterodimer as compared with the intact B 
domain is in perfect agreement with the analysis of clus- 
tered point mutations, which indicates additional weakly 
mutation-sensitive regions between the two essential mo- 
tifs (see M4, M5, M6, M8, and M9 in Figure 3). 
The Extinguished State of the TAT Gene 
Is Reflected by Changes in Protein 
Binding at the CRE 
To analyze the effect of the Tse-7 locus on protein binding 
in vivo, we have used the genomic footprinting technique. 
Changes in dimethylsulfate (DMS) reactivity revealing 
protein-DNA interaction in vivo have been detected at the 
TATCRE in FTO-PB cells as compared with XC cells (F. W., 
A. F. Stewart, M. B., D. Nitsch, and G. S., submitted). No 
difference in DMS reactivity was visible, however, when 
DNA from XC cells or HTC cells was compared with the 
naked control (Figure 5A). Thus, specific changes reveal- 
ing protein binding in vivo at the TATCRE motif mark cells 
in which the hepatocyte-specific enhancer is functional. 
The significance of the observed changes is highlighted 
by the fact that mutation of just the three bases protected 
from DMS attack completely abolished enhancer activity 
(construct M3 in Figure 3). No additional changes in DMS 
reactivity were detected in the entire B domain (data not 
shown). No changes were observed after induction for 2 
hr with forskolin or dexamethasone as shown in Figure 5A. 
Glucocorticoids do not affect activity of the hepatocyte- 
specific enhancer but rather act via a separate element at 
-2.5 kb (Jantzen et al., 1987), and forskolin elicits only a 
transient enhancement of the footprint pattern at the CRE 
with a peak after 30-50 min (F. W., A. F. Stewart, M. B., 
D. Nitsch, and G. S., submitted). 
We then asked whether changes in protein binding at 
the CRE can be detected in the presence of Tse-7. In 
7AE27 (Tse-7+) cells only a very weak in vivo footprint was 
seen at the CRE (Figure 58) compared with the strong 
footprint in FTO-2B (Tse-l-) cells (Figure 5A). The pres- 
ence of Tse-7 is therefore correlated with loss of footprint 
activity at the CRE. The full pattern reappeared, however, 
after induction with forskolin in 7AE27 (Tse-7+) cells (Fig- 
ure 6B). Thus, protein binding in vivo at the CRE faithfully 
reflects function of the enhancer: it is active in hepatoma 
cells, extinguished by Tse-7, and reactivated by CAMP in- 
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Figure 5. The In Vivo Footprint at the TATCRE Is Cell Type Specific and 
Affected by Tse-7 
(A) XC, FTO-26, and HTC cells were cultured overnight in serum-free 
medium, then induced for 2 hr with dexamethasone (dex) or with for- 
skolin (forsk.) or treated with 0.1% ethanol as solvent control (un). After 
mild trypsinization, cells were reacted with DMS and processed for 
genomic footprinting as described in Experimental Procedures. Thirty 
micrograms of Styl-cut genomic DNA per lane was electrophoresed on 
a 6% denaturing polyacrylamide gel. For comparison, purified genom- 
ic DNA (naked) was reacted in vitro with DMS. After electroblotting and 
covalent cross-linking to a nylon membrane, hybridization was per- 
formed with a single-stranded DNA probe recognizing the sequence 
from -3516 to -3643 on the upper strand. Guanosine residues from 
-3619 to -3675 of the upper strand are visible on the autoradiogram. 
Altered DMS reactivity of guanosine residues is marked with solid 
squares for enhancements and with open squares for protections. 
Numbers indicate the positions in base pairs relative to the start site 
of transcriptlon. The changes on the upper strand, visible on the auto- 
radiogram, are marked to the right of the sequence blowup. Enhance- 
ments and protections on the lower strand are marked to the left of the 
sequence blowup (data not shown). The part of the sequence homolo- 
gous to the CRE consensus is boxed. 
(6) 7AE27 @e-i+) and XC cells were processed exactly as described 
in (A). Guanosine residues from -3619 to -3675 of the upper strand 
are visible on the autoradiogram. 
duction in the Tse-7+ cell line (see Table 2 and Figure 2B). 
This suggests that changes in protein binding at the CRE 
are directly involved in negative regulation by Tse-7. 
The CRE Is the Target for Be-1 
Consequently, we analyzed the role of the TATCRE in re- 
pression by Tse-7. This was complicated by the fact that 
a dimer of the BI oligonucleotide conferred relatively weak 
basal activity (see 2x BI in Figure 4 and Table 3). How- 
ever, a strong synergistic effect was observed when the 
number of tandemly repeated BI oligonucleotides cloned 
in front of the TK promoter was increased. This led to a 
drastic increase in basal stimulation with a concomitant 
decrease in the foldness of induction by forskolin (Figure 
6 and data not shown). We made use of this observation 
for a more sensitive detection of negative regulation and 
used a pentamer of the BI oligonucleotide. As control we 
included a construct with two copies of the SV40 enhancer 
in front of the TK promoter (pTK14C), which we have 
shown to be equally expressed in 7AD7 @e-l-) and 
7AE27 (TM-~+) cells and to be unresponsive to forskolin in 
both cell lines when compared with a variety of different 
promoters (see Table 2). The results shown in Figure 6 
clearly document that the BI oligonucleotide is responsive 
to Tse-7. The basal level of expression of construct 5x BI 
was about 20-fold reduced in 7AE27 (TM-~+), and this ef- 
fect was fully reversed upon induction with forskolin. There- 
fore, we conclude that the CRE motif mediates repression 
by Tse-7. Expression of a pentamer of the Bill oligonucleo- 
tide was 3-fold reduced in 7AE27 (TM-~+) cells but was 
not inducible with forskolin (data not shown). Thus, the 
CRE is the primary target for repression of the enhancer 
by Tse-7. 
Hepatocyte Specificity of the Enhancer Is 
Generated by Combinatorial Use of Cell-Specific 
Elements Fully Dependent on Synergistic Action 
Knowing that Tse-7 exerts its negative effect via a CRE that 
is essential for basal activity of a hepatocyte-specific en- 
hancer, we asked which role this CRE played to determine 
cell type specificity of the enhancer. To this end, we tested 
the two elements that are essential and together sufficient 
for enhancer function (BI and 8111) individually in five 
different cell lines. As shown in Table 3 the intact B domain 
Table 3. Cell Type-Specific Activity of Elements BI and Bill 
Relative CAT Activity in Extracts from Transfected Cell Line@ 
FTO-PB HTC xc HepG2 HeLa 
Construct - forsk. - forsk. - forsk. - forsk. - forsk. 
pBLCAT2 1 .o 1.9 1.0 1.1 1.0 0.9 1.0 1.0 1 .o 1.3 
TTCBO (B domain)b 36.0 154.0 2.2 4.8 0.8 0.8 0.9 2.0 1.3 1.4 
2x Bib 2.8 56.0 1.9 5.2 1 .o 1.1 1.1 1.9 19.0 24.0 
2 x Blllb 37.0 72.0 2.4 3.2 0.5 0.5 6.5 8.2 0.6 0.6 
Bl/Blllb 15.0 80.0 2.2 4.3 0.9 0.8 2.4 2.6 2.4 3.5 
2x SOMC 1.8 15.0 1.5 2.9 0.7 0.7 1.2 1.4 5.7 4.9 
SOM/BlllC 22.0 102.0 2.7 4.6 0.7 0.7 2.9 4.6 3.0 3.6 
a All cell lines were electroporated under identical conditions (see Experimental Procedures) with 10 wg of the respective plasmid and 1 pg of 
RSVlucA/H as internal reference. Cells were split onto duplicate plates and kept in medium with 10% charcoal-stripped serum and were induced 
with 10 HIM forskolin (forsk.) or treated with 0.1% ethanol as solvent control (-) directly after electroporation. Extracts were prepared after 50 
hr and assayed for CAT and luciferase activity. CAT values were corrected and are given as relative activity by arbitrarily setting the activity of 
the uninduced TK promoter in pBLCAT2 to 1. Absolute values for pBLCAT2 are 1.7 pmollmin per mg in FTO-2B, 19 pmollmin per mg in HTC. 
395 pmol/min per mg in XC, 12 pmollmin per mg in HepG2, and IO pmollmin per mg in HeLa cells. 
b See Figure 4. 
c The SOM oligonucleotide encompasses the sequence from - 31 to - 56 of the rat somatostatin gene (Montminy et al., 1986). 
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Figure 6. The TATCRE Is Responsive lo Tse-7 
Duplicate cultures of 7AD7 @e-l-) and 7AE27 (Tse-I+) cells were 
transfected by lipofection (see Experimental Procedures) with the con- 
structs depicted in the diagram. Twenty hours after addition of the 
DNA-lipid complex, medium was changed and incubation was con- 
tinued under serum-free conditions throughout an expression period 
of 65 hr. Forskolin (IO uM) or 0.1% ethanol was added 22 hr before cells 
were harvested. CAT activity was corrected for protein and is given as 
relative activity, arbitrarily setting the value of construct pTK14C to 100. 
Absolute values for pTK14C are 64.6 pmollmin per mg in 7AD7 and 67.3 
pmollmin per mg in 7AE27 cells. Construct 5x BI is exactly analogous 
to 2x 81 as described in the legend to Figure 4, but contains five tan- 
dem copres of the BI oligonucleotide in sense orientation. In construct 
pTK14C two copies of the SV40 enhancer are placed in front of the TK 
promoter. 
(construct TTC80) conferred strong activation onto the TK 
promoter in FTO-PB cells, but only a minimal effect was 
seen in HTC cells, and no effect at all was seen in any 
other cell line tested. This documented that the B domain 
of the enhancer could confer specificity for highly differen- 
tiated hepatoma cells onto a heterologous promoter (com- 
pare with Table 1). A dimer of the BI oligonucleotide was 
responsive to CAMP in FTO-2B cells, responded weakly in 
HTC cells, and was inactive in XC or HepG2 cells. How- 
ever, it was surprising to find a strong constitutive stimula- 
tion in HeLa cells. Thus, the CRE motif alone cannot fully 
account for restriction of enhancer activity to FTO-2B 
cells. A dimer of the somatostatin (SOM) CRE paralleled 
the activity of the TATCRE in the different cell lines. The 
second essential component of the enhancer (BIII motif) 
is apparently hepatoma specific: it is inactive in XC and 
HeLa cells, strongly active in well-differentiated rat hepa- 
toma cells (FTO-2B), moderately active in HepG2, and 
very weakly active in HTC cells. As expected, strong activ- 
ity of the BllBlll heterodimer or a SOMlBlll heterodimer 
was only observed in FTC-2B cells where both essential 
elements are fully functional. Thus, the basic principle 
tightly restricting activity of the enhancer to well-differenti- 
ated rat hepatoma cells seems to involve combinatorial 
use of elements with distinct cell type specificity that are 
functionally interdependent. 
The experiments reported here document a triple role for 
a CRE: first, it is essential for function of a liver-specific 
enhancer; second, it mediates negative regulation of this 
enhancer by Tse-1; and third, it responds to CAMP induc- 
tion in Tse-7+ cells, thereby reverting repression by Tse-7. 
Thus, the functional antagonism between Tse-7 and the 
CAMP pathway in monochromosomal hybrids (Thayer and 
Fournier, 1989; Ruppert et al., 1990) is reflected by a 
colocalization of sequences mediating CAMP and Tse-7 re- 
sponse. 
How Does Tse-1 Affect Protein Binding at the CRE? 
Several mechanisms of action can be envisaged that re- 
sult in repression of the TATCRE, accompanied by 
changes in protein binding at this site. Tse-7 might either 
modulate the DNA binding affinity or intracellular localiza- 
tion of a TATCRE binding protein or regulate its abun- 
dance. Alternatively, Tse-7 might be a repressor compet- 
ing for binding with a TATCRE binding factor. 
By genomic footprinting we have observed that in the 
cell line 7AE27 (Tse-7+), footprint activity at the TATCRE 
increases after CAMP induction, even if protein synthesis 
is completely blocked by cycloheximide (data not shown). 
Thus, a posttranslational event seems to contribute to the 
switch from the extinguished to the expressing state. 
Cotransfection of an expression vector encoding the cata- 
lytic subunit of protein kinase A is sufficient to overcome 
repression of TATCRE function by Tse-7 in 7AE27 (Tse-7+) 
cells (A. S. and M. B., unpublished data). This was ex- 
pected as protein kinase A mediates intracellular CAMP 
effects (for review see Edelman et al., 1987). Thus, it is 
very tempting to speculate that Tse-7 might change the 
phosphorylation state of a protein important for TATCRE 
function, for example, via a specific phosphatase activity. 
We detected a TATCRE binding activity in hepatoma nu- 
clear extracts that increased upon CAMP induction (F. W., 
A. F Stewart, M. B., D. Nitsch, and G. S., submitted). As 
binding activity of CRE binding protein (Hoeffler et al., 
1988; Gonzalez et al., 1989) is not enhanced by kinase 
A-mediated activation (Yamamoto et al., 1988) the TAT- 
CRE binding activity might be a distinct member of the 
CRE binding protein/ATF family of transcription factors 
(Hai et al., 1989; Maekawaet al., 1989; for reviews see Kar- 
in, 1989; Mitchell and Tjian, 1989). Other possible mech- 
anisms of Tse-7 action might involve sequestration of a 
TATCRE binding protein as described for NF-KB (Baeuerle 
et al., 1988). Analysis of the state of phosphorylation of the 
TATCRE binding protein in extinguished (Tse-7+) cells or 
its possible association with an inhibitory subunit in these 
cells may allow elucidation of the mode of action of Tse-7. 
Down-regulation of the mRNA encoding the cell type- 
specific transcription factor GHFl, which is essential for 
growth hormone gene transcription, has been found in so- 
matic cell hybrids between pituitary cells and fibroblasts, 
where expression of the growth hormone gene is extin- 
guished (McCormick et al., 1988). lmmunoglobulin heavy 
and K light chain gene promoters and the heavy chain en- 
hancer are targets for extinction in myeloma x fibroblast 
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somatic cell hybrids (Junker et al., 1988) and this is ac- 
companied by down-regulation of the mRNA coding for 
the lymphoid-specific transcription factor Ott-2 (OTF-2) 
(Bergman et al., 1990; P. Matthias and S. Junker, personal 
communication). Thus, in these two systems fibroblast 
factors suppress synthesis of transcription factors critical 
for cell type-specific gene transcription. However, in con- 
trast to Tse-7, these fibroblast factors have not yet been de- 
fined by genetic analysis, and extinction in whole cell 
hybrids might well be the result of several factors acting 
via distinct mechanisms. Evidence for additional mecha- 
nisms involved in extinction of the growth hormone gene 
(Triputti et al., 1988) and the immunoglobulin heavy chain 
gene (Zaller et al., 1988; Yu et al., 1989) has been re- 
ported. 
Two observations argue against the possibility that Be-7 
itself binds at the TATCRE site and represses by displac- 
ing a transcription factor required for function. First, ge- 
nomic footprinting indicates loss of protein binding at the 
TATCRE in the extinguished state. Second, none of our 
clustered point mutations selectively affects repression. 
Double Control of Cell Type-Specific 
Enhancer Activity 
The hepatocyte-specific enhancer described in this report 
provides a clear paradigm for mechanisms that guarantee 
a high degree of cell type specificity of transcriptional con- 
trol. We defined two distinct sequence motifs absolutely 
essential for function of this enhancer. Both motifs are in- 
active on their own but stimulate transcription of a heterol- 
ogous promoter upon multimerization. When both motifs 
are linked, they act synergistically, and an element is 
generated with all regulatory characteristics of the en- 
hancer at -3.6 kb. As a consequence of this functional in- 
terdependence, the enhancer works only in cells where 
both elements are active. This is only the case in highly 
differentiated rat hepatoma cells (FTO-2B and 7AD7). The 
parallel behavior of the TATCRE and the SOMCRE in 
different cell lines suggests that the functional state of the 
CAMP signal transduction pathway is important for cell 
type-specific expression of the TAT gene. In other words, 
Tse-7 might elicit gene- and cell-specific effects by interfer- 
ing with a signal transduction pathway shared by many 
different cell types. Constitutive activation of the CAMP 
pathway in HeLa cells was noted previously (Iguchi-Ariga 
and Schaffner, 1989). 
Since recognition of the modular structure of enhancers 
and promoters, it has been suggested that modularity 
might be an economical mechanism to create a large 
number of regulatory patterns by combinatorial use of a 
smaller number of regulatory proteins (Serfling et al., 
1985; Dynan, 1989). Here, we provide a particularly clear 
example to support this concept. The observation of coor- 
dinate control of overlapping sets of liver genes by two 
frans-acting loci (see Ruppert et al., 1990) provides ge- 
netic evidence for the same concept. Probably, in most 
nonliver cells Tse-7 leads to repression of basal activity of 
the TATCRE, and at the same time the hepatoma-specific 
Bill motif is inactive. This leads to two levels of control of 
cell type-specific enhancer activity. Therefore, the modu- 
lar structure provides not only an economical but also a 
very restrictive mechanism for cell type-specific tran- 
scriptional control. 
Developmental Regulation of 
TAT Gene Transcription 
Expression of TAT first rises around birth, but can be 
prematurely activated by administration of CAMP in utero 
(see Introduction). Tse-7 activity is expressed in mouse 
hepatoma cells with a fetal liver phenotype (Peterson and 
Fournier, 1989), but is absent in highly differentiated hepa- 
toma cells expressing adult hepatic markers. As Tse-7 and 
CAMP both act via a CRE, these observations suggest a 
model for regulation of the timed onset of expression 
based on the antagonism between Tse-7 and the CAMP 
pathway. As the balance between activity of Tse-7 and the 
CAMP pathway is critical for function of the TATCRE and 
as this element has to cooperate with a second essential 
element (8111) the enhancer can work as a sensitive 
switch responding to changes in the Tse-l/CAMP balance 
with dramatic changes in overall activity. Thus, decrease 
of Tse-7 activity during liver development would render the 
repressed TAT gene increasingly responsive to hormonal 
stimulation toward the end of gestation. The timed onset 
of TAT expression around birth would then be triggered by 
the strong release of gluconeogenic hormones acting via 
the CAMP pathway, resulting from neonatal hypoglyce- 
mia. In the accompanying paper we provide genetic evi- 
dence that Tse-7 coordinately regulates a set of liver- 
specific genes that are all inducible via the CAMP pathway 
(Ruppert et al., 1990). We anticipate that the genes share 
regulatory elements with similar properties. We are now 
testing whether a Tse-7 response element can specify the 
timed onset of expression in transgenic mice. If this con- 
cept were correct, monochromosomal hybrids would rep- 
resent a cell culture model to study a developmental acti- 
vation process triggered by hormones. 
Experimental Procedures 
Plasmid Constructions 
All constructs encompassing the rat TAT promoter are based on the 
plasmid TATCAT -2950/+62, which is described in Jantzen et al. 
(1987). TATCAT -4289/+62 was generated by inserting further up- 
stream sequences from a phage clone (see D. Nitsch, A. F. Stewart, 
M. B., A. Mestril, F. W., and G. S., submitted). The endpoints of 5’ and 
3’ internal deletions (see Figure 2A) all correspond to restriction sates 
in the TAT sequence that were used for construction (details available 
upon request). The sequence of the TAT upstream region will be filed 
to the EMBL data bank. The set of clustered point mutations was 
generated by the oligonucleotide cassette technique (Grundstrbm et 
al., 1965). A 131 bp Sphl-Xbal fragment was assembled from 14 oligo- 
nucleotides and ligated directly into TATCAT -4289/+62 via naturally 
occurring restriction sites (Sphl at -3675 and Xbal at -3544). Thus, 
the cluster of mutations is the only sequence change in the entire con- 
struct. Details of the procedure will be published elsewhere. 
Constructs with the TK promoter are based on the vector pBLCAT2 
(Luckow and Schutz. 1987). The TTC series (see Figure 28) was con- 
structed by inserting various restriction fragments from the enhancer 
region in sense orientation into the polylinker of pBLCAT2 (details avail- 
able upon request). Togenerate2x BI, 5x BI. and 2x SOM the follow- 
ing complementary oligonucleotides were synthesized, gel-purified, 
head-to-tail tandemerized via the cohesive Xbal and Spel ends, and 
cloned in sense orientation into the Xbal site of pBLCAT2. 
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BI oligonucleotide: 
CTAGATGCAGCTTCTGCGTCAGCGCCAGTATA 
TACGTCGAAGACGCAGTCGCGGTCATATGATC 
SOM oligonucleotide: 
CTAGATCCTTGGCTGACGTCAGAGAGAGAGTA 
TAGGAACCGACTGCAGTCTCTCTCTCATGATC 
In the same way 2x Bill and 5x Bill were generated from the following 
complementary oligonucleotides, which have Bglll and BamHl cohe- 
sive ends and were cloned into the BamHl site of pBLCAT2: 
Bill oligonucleotide: 
GATCTGCTGCTCTTTGATCTG 
ACGACGAGAAACTAGACCTAG 
Construct BllBlll has one copy of the BI oligonucleotide rn the Xbal site 
and one copy of the Bill oligonucleotide in the BamHl site, both in 
sense orientation. SOMlBlll was constructed analogously. For mutant 
versions of these constructs, oligonucleotides with the M3, M415. or 
Ml2 cluster of point mutations (see Figure 3) but otherwise identical, 
were used. Standard cloning procedures are described in Ausubel et 
al. (1988). All constructions were verified by plasmid sequencing (Chen 
and Seeburg, 1985) using T7 polymerase and the SequenaseTM pro- 
tocol (US Biochemical). Plasmids were grown in Escherichia co11 
HE101 and purified by alkaline lysis and two successive CsCl gra- 
dients, followed by dialysis and ethanol precipitation 
Cell Culture and Transfections 
The rat hepatoma lines FTO-2B, 7AD7, and 7AE27 are described rn KII- 
lary and Fournier (1984) and Leach et al. (1989). Frozen stocks from 
subclones of these lines were prepared, and all experiments were 
done with aliquots from the same stock, freshly thawed every 4-6 
weeks. Hepatoma%ells were cultured rn a 1:l (vol/vol) dilution of Dul- 
beccos’s modified Eagle’s medium (DMEM) and Ham’s F12 medium. 
For XC and HeLa cells DMEM was used. Media were supplemented 
with 10% fetal calf serum, 100 U/ml penicillin, 100 @g/ml streptomycin, 
10 mM HEPES (pH 7.4) and 2 mM glutamine. The medium for 7AD7 
and 7AE27 additionally contained 800 rig/ml G418 (GIBCO, Bethesda 
Research Laboratories). Cells were grown at 37% in 5% COs. 
Electroporation (Fromm et al., 1985; Chu et al., 1987) was performed 
with the Gene PulserTM and Capacitance ExtenderTM from Bio-Rad. 
Cells were trypsinized, washed with Cap’- and Mgs+-free phosphate- 
buffered saline and resuspended in phosphate-buffered saline at a 
concentration of 2 x lo7 cells/ml (FTO-2B, HepG2, and HeLa) or 1 x 
10’ cells/ml (XC and HTC). Five hundred milliters of the suspension 
was mixed with 10 ug of plasmid DNA plus 1 Kg of the reference plas- 
mid RSVIucAIH. In this construct, provided by A. Hecht, the firefly Iu- 
ciferase gene (de Wet et al., 1987) is driven by the RSV promoter and 
enhancer. Cells were pulsed immediately after transfer to electropora- 
tion cuvettes (Bio-Rad) at room temperature with 960 nF and 250 V. 
After 5-10 min the cells were diluted in medium containing charcoal- 
stripped fetal calf serum and plated. 
,For lipofection (Felgner et al., 1987) 2 x lo6 to 4 x 10s cells were 
plated onto 60 mm dishes 1 day before transfection. Both 0.5 pmol of 
plasmid DNA and 33 ng of the LipofectinTM reagent (provided by G. 
Ringold or purchased from GIBCO, Bethesda Research Laboratones) 
were diluted separately in 500 &I of HBS buffer (20 mM HEPES [pH 
7.41, 150 mM NaCI). Where indicated, 0.05 pmol of the reference plas- 
mid RSVlucAlH was included. The DNA and LipofectinTM dilutions 
were mixed at room temperature and lo-15 min later added to the cells, 
previously washed twice with serum-free medium. After a 3 hr incuba- 
tion at 37% with the DNA/LipofectinTM mix, 2 ml of serum-free 
medium was added, and incubation was continued overnight (12-16 
hr). Medium was then replaced or cells were split for inductions. 
CAT and Luciferase Assays 
Cells were washed twice with phosphate-buffered saline, harvested in 
1 ml of 150 mM NaCI, 40 mM Tris (pH 7.4) 1 mM EDTA, and collected 
by low speed centrifugation. Extracts were prepared in 300 nl of 250 
mM Tris (pH 7.8) 1 mM EDTA, 1 mM dithiothreitol, 0.2% Saponin by 
3 cycles of freezing and thawing and were cleared by centrifugation 
at 10,000 x g, at 4% for 20 min. The protein concentration was deter- 
mined by the Bradford assay (Bradford, 1976). CAT assays were per- 
formed at 37% in a total volume of 200 nl with 250 mM Tris (pH 7.8) 
5 mM EDTA, 2 mM acetyl coenzyme A (Pharmacia), and 1.25 trCi/ml 
r4C chloramphenicol (New England Nuclear) final concentrations. Ex- 
tracts were heat treated (10 min, 80%) to inactivate deacetylase activ- 
ity (Crabb and Dixon, 1987). Under these conditions the assay was Im- 
ear up to several hours and up to 100 nl (-1 mg) of extract. Routinely, 
the assay was run for l-2 hr with the amount of extract required to con- 
vert 0.5%-50% of the substrate to the acetylated form. Assays outside 
this range were repeated using the appropriate amount of extract or 
a different reaction time. After thin-layer chromatography the un- 
acetylated chloramphenicol and the acetylated forms were quantified 
by liquid scintillation counting to determine the conversion rate. The 
activity is expressed as picomoles of acetylated chloramphenicol per 
minute per milligram of extract protein or as relative activity. Luciferase 
activity was measured in 50 trl of the freshly prepared extract as de- 
scribed in de Wet et al. (1987). 
RNA Start Site Mapping 
Total RNA was extracted by the guanidimum rsothrocyanate/CsCl 
cushion method (Chirgwin et al., 1979). TATCAT-specific mRNA was 
quantitated, and transcription start sites were determined with a 
ribonuclease protection assay (Melton et al., 1984) using a uniformly 
labeled probe spanning positions -108 to +216 of TATCAT (Jantzen 
et al., 1987). One hundred micrograms of RNA was hybridized to 10 
fmol (1.6 x lo6 dpm) of gel-purified probe, digested at 30°C for 1 hr 
with 10 *g/ml RNAase A and 100 U/ml RNAase Tl. 
Genomic Footprinting 
Cells (0.5 x lo* to 1 x 108) were collected by mild trypsinization and 
resuspended in 1 ml of serum-free medium before addition of DMS. All 
subsequent steps were performed according to Becker and Schiitz 
(1988) except that presaturation of vector-specific sequences with 
sheared single-stranded vector DNA prior to hybridization was unnec- 
essary, as a cDNA probe of high specific activity was synthesized from 
an RNA template as described (Weih et al., 1988). The probe used 
(HS127) recognized positions -3516 (Styl) to -3643 (Hhal). 
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